| Expected time (years) to ART initiation |
---|
PWID | Persons who did not inject drugs | Difference |
---|
| RMST | 95% CIc | RMST | 95% CI | RMST | 95% CI |
---|
All years | 1.51 | 1.44, 1.87 | 1.43 | 1.37, 1.64 | 0.08 | −0.10, 0.38 |
1996–2001 | 1.61 | 1.51, 2.25 | 1.54 | 1.48, 1.91 | 0.07 | −0.26, 0.67 |
2002–2007 | 1.48 | 1.25, 2.32 | 1.61 | 1.26, 2.09 | −0.13 | −0.82, 0.72 |
2008–2014 | 2.87 | 2.66, 3.52 | 1.48 | 1.34, 2.73 | 1.39 | 0.15, 1.98 |
- aEstimates are standardized to the distribution of sex, race, AIDS diagnosis, prior ART mono- or dual-therapy, age, CD4 cell count and log10 HIV viral load in the total sample at clinic enrollment using inverse probability of exposure weights
- bThe RMST spent not on ART but Alive and Retained in Clinic refers to the difference of the integration of the 1-CIF for ART initiation minus the CIF for the composite of mortality and loss-to-clinic
- cBased on integration between 1-CIF for ART 2.5th and 97.5th percentiles of 10,000 non-parametric bootstrap resamples